CVA Family Office’s Nutanix NTNX Stock Holding History

CVA Family Office’s Portfolio NTNX Stock Details NTNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.22K	Sell	122 -26	-18%	-$1.18K	﹤0.01%	1191
2026 Q1	$5.63K	Buy	+148	New	+$6.24K	﹤0.01%	1191
2025 Q3	–	Sell	-7	Closed	-$535	–	1330
2025 Q2	$535	Hold	7	–	–	﹤0.01%	1217
2025 Q1	$489	Buy	+7	New	+$484	﹤0.01%	1279

Other funds holding NTNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

CVA Family Office's NTNX Position: Q2 2026 in Review

CVA Family Office reduced its Nutanix (NTNX) stake by 18% in Q2 2026, selling an estimated $1.18K and leaving 122 shares worth $6.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

CVA Family Office first reported a position in NTNX in Q1 2025 and has held it in 4 quarters since. 559 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

CVA Family Office held 122 shares of Nutanix worth $6.22K as of Q2 2026.
CVA Family Office sold 26 Nutanix shares in Q2 2026, an estimated $1.18K.
Nutanix made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1191 holding.
CVA Family Office first reported a position in Nutanix in Q1 2025 and has held it in 4 quarters since.
559 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.